Portfolio-scale delivery
Consistent SAS/CDISC standards applied across concurrent studies keep data structures comparable as a program grows, reducing rework when studies are pooled or compared.
Why pharma sponsors choose us
Built for portfolio-scale programs
Three ways an integrated Biometrics and Clinical Operations model changes how a multi-study pipeline runs.
Regulatory-ready data
Biostatistics and medical writing work from the same dataset and timeline, so CSRs, ISS/ISE, and submission packages move forward without last-minute reconciliation.
Staffing that scales with the pipeline
From a single embedded specialist to a full study team, FSP in-sourcing flexes as programs move through the portfolio.
Common questions
Before you scope a portfolio engagement
Running a multi-study pharma portfolio?
Tell us your therapeutic areas and study phases — we'll map a Biometrics and Clinical Operations model that scales with the pipeline.